- Case report
- Open Access
Fetal aortic valvuloplasty: first report of two cases from Saudi Arabia
Journal of Cardiothoracic Surgery volume 15, Article number: 150 (2020)
Fetal aortic stenosis may progress to hypoplastic left heart syndrome (HLHS), which carries a poor prognosis. We report two infants with fetal aortic stenosis successfully treated with fetal aortic valvuloplasty (FAV) using balloon dilatation.
Of five fetuses with aortic stenosis fulfilling the FAV criteria of severe aortic stenosis with a left ventricular length Z-score of ≥ − 2, retrograde flow in the transverse aortic arch, left-to-right flow across the foramen ovale, monophasic mitral inflow, and significant left ventricular dysfunction, we obtained permission for FAV in two fetuses. FAV was performed successfully under echocardiographic guidance using balloon dilatation. Both fetuses survived to birth. During FAV, mild pericardial effusion developed when introducing the stylet needle in the second fetus, and this resolved within 48 h. No intraprocedural complications occurred in the first patient, and no maternal complications occurred. The first infant underwent the Ross procedure after birth and is currently 7 years old and doing well. The second patient underwent aortic and mitral valve repair with endocardial fibroelastosis resection approximately 2 weeks after birth, which temporarily addressed the mitral valve stenosis; high doses of inotropes were subsequently required. The infant died of sepsis at 2 months of age.
FAV using balloon dilatation to treat fetal aortic stenosis was successful in our two patients, with subsequent neonatal biventricular repair resulting in long-term survival in one patient and death secondary to sepsis in the second patient.
Hypoplastic left heart syndrome (HLHS) occurs in up to 3% of infants with congenital heart disease and is considered the main cause of death in this population . The syndrome is a spectrum of left heart growth abnormalities in which the left heart is unable to support cardiac output. The underlying mechanisms are controversial, although there is strong evidence for a genetic component in a small subset of patients. This is consistent with a multifactorial etiology. In some cases, HLHS is established early in pregnancy . In other cases, however, HLHS develops secondary to severe aortic stenosis (AS) in mid-gestation. The left ventricle (LV) is usually initially normal, but as gestation progresses, the LV may become dilated with impaired function. This further decreases the potential growth of the LV, leading to HLHS [2, 3].
Several reports have described the performance of FAV for early relief of the obstruction at the aortic valve (AOV). The goal of this procedure is to modify the natural history of the disease, which might preserve left heart growth and prevent HLHS [4,5,6,7,8,9]. In one study, biventricular circulation was achieved after birth in about 59% of cases, with a per-procedural pregnancy loss rate of 4% .
In this study, we share our initial experience of initiating an FAV program in two patients diagnosed with critical AS, aiming to relieve the obstruction of the AOV before the development of irreversible damage to the LV.
Since we began our fetal intervention program in 2009, 10 fetal cases have been referred for treatment of critical AS. Five of these cases fulfilled the following criteria for FAV: severe AS with a left ventricular length Z-score of ≥ − 2, retrograde flow in the transverse aortic arch, left-to-right flow across the foramen ovale (FOV), a monophasic mitral inflow pattern, and significant left ventricular dysfunction . Only three families consented to the fetal intervention. One fetus had hydrops fetalis and died before the procedure. In the remaining two cases, the parents were counseled about the nature of the procedures, and informed consent was obtained.
An ideal fetal position was obtained (left side of fetal chest wall anteriorly oriented, left outflow tract parallel to intended cannula course). Under continuous echocardiography guidance (iU22 in Case 1 and EPIQ 7C in Case 2; Philips Healthcare, Andover, MA, USA), a 15-cm-long 18-gauge cannula with a stylet needle was introduced into the maternal abdomen and directed from the fetal thorax to left ventricular apex, aiming toward the AOV (Fig. 1a, b). After advancing the cannula until just beneath the AOV, the stylet needle was removed, and a 0.014-in. guide wire with a coronary dilatation catheter was introduced across the AOV. A 4.0-mm balloon was used, and the balloon was inflated twice by a pressure gauge in both cases.
After withdrawal of the balloon, we noted immediate antegrade flow across the AOV (Fig. 2a, b) and a moderate degree of aortic regurgitation (AR) by color Doppler in both cases (Fig. 3), indicating technical success of the procedures.
No complications occurred in Case 1 (Video 1, pre and post AV balloon dilatation). Mild pericardial effusion developed during needle introduction in Case 2 (Video 2, pre and post AV balloon dilatation), but resolved spontaneously during the next 48 h. No maternal complications occurred in either case.
Additional file 1: Video 1. Case 1 pre and post AV balloon dilatation.
Additional file 2: Video 2. Case 2 pre and post AV balloon dilatation.
A 25-year-old pregnant woman was referred at 31 weeks of gestation. She had no significant medical history. Detailed fetal echocardiography showed cardiomegaly with dilation and poor contraction of the LV. The AOV was immobile with no forward flow in the left outflow tract (Fig. 2a), and blood filled the aorta by reverse flow from the ductus arteriosus. The aortic annulus diameter was 3.8 mm. We also observed left-to-right flow across the FOV, a monophasic mitral inflow pattern, mild mitral regurgitation (MR), and a left-sided aortic arch. The fetus also had mild ascites and pleural effusion, suggesting hydrops and heart failure secondary to severe critical AS. No extracardiac anomalies were observed.
The fetal orientation was favorable for intervention from the start such that a direct approach as described above was smoothly performed from the apex and was successful on the first attempt. Serial follow-up fetal echocardiography assessments showed improvement of left ventricular function, improvement of aortic flow, disappearance of MR, and reversal of the shunt across the FOV. The fetus was delivered by normal vaginal delivery with a birth weight of 2.7 kg. Postnatal echocardiography showed unicuspid thickening and a stenotic AOV with a mean pressure of 58 mmHg and no AR. The neonatal Ross procedure was performed after postnatal balloon dilatation had resulted in residual severe AV stenosis and moderate AR. At the time of this writing, the child was 7 years old and doing well.
A 31-year-old pregnant woman was referred at 28 weeks of gestation. Her previous child had died of a neurological disorder in the first year of life. Detailed fetal echocardiography showed that the LV was dilated with severely decreased ventricular function and that multiple sites of endocardial fibroelastosis (EFE) were present in the LV endocardium and MV chordae and papillary muscles (Fig. 4). The AOV was thickened, dysplastic, and immobile with no forward flow. Retrograde flow was seen from the ductus arteriosus, the aortic annulus diameter was 3.2 mm, left-to-right flow was present across the FOV, and a monophasic inflow pattern was observed. Trivial MR was present with no sign of fetal hydrops. No extracardiac anomalies were present.
The fetal position was initially unfavorable with the spine facing anteriorly, but spontaneous fetal movement resulted in a more suitable position about 2 h later. The technical success of the procedure appeared to be confirmed by an improvement in aortic flow on Doppler echocardiography (Fig. 3) (the ventricular function did not improve, although the AR disappeared). A second attempt to perform FAV was discussed; however, some forward flow was seen through the AOV, prompting a wait-and-see approach. The FOV continued to exhibit left-to-right shunting, and there was no further regression of the LV growth.
The male fetus was delivered at 37 weeks of gestation by Caesarean section with a birth weight 2.9 kg. Postnatal echocardiographic assessment showed a dysplastic bicuspid and stenotic AOV with forward flow and measuring 4 mm. Mild MR was present, and the MV measured 8 mm. The infant had severely impaired left ventricular function and multiple foci of EFE. He did not require prostaglandin.
The initial strategy was to promote biventricular circulation. Clear forward flow was present in the AOV, so the infant was started on high-dose inotrope therapy to improve cardiac function. The left ventricular systolic function gradually began to improve in the second week of life, and with this improvement in function, the MV inflow showed significant stenosis and significant EFE involved the whole MV apparatus. The infant underwent aortic and MV repair and EFE resection. Immediately postoperatively, the MV stenosis decreased; however, few days later the left atrial pressure began to gradually increase again with increase in MV stenosis and elevated pulmonary artery pressure. This could be explained mitral valve disease. The patient continue high ventilator setting due to pulmonary oedema. The patient eventually died of sepsis at 2 months of age.
Several mechanisms been proposed for the development of hypoplasia or borderline size of the left heart structures. The most widely proposed mechanism suggests that this clinical entity starts as severe or critical AS and progresses to an increased left ventricular afterload, resulting in decreased systolic and diastolic function. Reverse shunting across the FOV decreases the volume of blood crossing the MV, thus decreasing the further potential for growth of the left heart structures [2, 3].
Chronic elevation of ventricular pressure in the setting of AS may not only affect the growth of the left heart structure but may also damage the fetal myocardium, thus affecting ventricular systolic and diastolic function [11, 12]. Diastolic dysfunction can result from increased stiffness of the ventricle, which replaces the normal myocardial tissues with fibrotic collagen called EFE [13,14,15].
In Case 2, the fetus had significant EFE affecting the left ventricular endocardium and MV apparatus (grade 3 according to McElhinney et al. ). However, even after FOV, the left ventricular function did not improve until the postnatal period; where inotropic support initiated and ventricle function start to improve, the pressure gradient across the MV start to show up .. The combination of aortic stenosis, mitral stenosis and significant EFE in a neonate, even with an adequate LV size, is a risk factor for a poor outcome [16,17,18].
This report describes our growing experience with first-attempt FAV to establish a foundation for future clinical practice of FAV in Saudi Arabia. Both FAV procedures in this report were technically successful as indicated by inflation of the balloon across the valves and improvement in anterograde color flow and/or new AR, as previously defined [19, 20].
Previously published data revealed high success rates of FAV (range, 70–81%) and improved rates of achieving biventricular circulation (range, 43–67%) [10, 20, 21]. However, patient selection remains challenging, especially in patients with extensive EFE affecting the valves and myocardium. More data are required to assess the impact of FAV on achieving biventricular circulation.
Our initial experience described in this report will help to establish the future clinical practice of FAV. Careful selection of patients and centralization of experiences in medical institutions with high levels of technical skill may improve the perinatal outcomes of fetal intervention in the region. .
Availability of data and materials
Not applicable (medical records and images are available in the hospital).
Hypoplastic Left Heart Syndrome
Fetal Aortic Valvuloplasty
Grossfeld P, Nie S, Lin L, Wang L, Anderson RH. Hypoplastic left heart syndrome: a new paradigm for an old disease? J Cardiovasc Dev Dis. 2019;6:E10.
Tworetzky W, Wilkins-Haug L, Jennings RW, van der Velde ME, Marshall AC, Marx GR, et al. Balloon dilation of severe aortic stenosis in the fetus: potential for prevention of hypoplastic left heart syndrome. Candidate selection, technique, and results of successful intervention. Circulation. 2004;110:2125–31.
Makikallio K, McElhinney DB, Levine JC, Marx GR, Colan SD, Marshall AC, et al. Fetal aortic valve stenosis and the evolution of hypoplastic left heart syndrome: patient selection for fetal intervention. Circulation. 2006;113:1401–5.
Suh E, Quintessenza J, Huhta J, Quintero R. How to grow a heart: fibreoptic guided fetal aortic valvotomy. Cardiol Young. 2006;16(Suppl 1):43–6.
Yoon SY, Won HS, Lee MY, Cho MK, Jung E, Kim KS, et al. First reported case of fetal aortic valvuloplasty in Asia. Obstet Gynecol Sci. 2017;60:106–9.
Arzt W, Wertaschnigg D, Veit I, Klement F, Gitter R, Tulzer G. Intrauterine aortic valvuloplasty in fetuses with critical aortic stenosis: experience and results of 24 procedures. Ultrasound Obstet Gynecol. 2011;37:689–95.
Maxwell D, Allan L, Tynan MJ. Balloon dilatation of the aortic valve in the fetus: a report of two cases. Br Heart J. 1991;65:256–8.
Gül A, Saygılı A, Kavuncuoğlu S, Ceylan Y. Balloon valvuloplasty for critical aortic stenosis in a fetus: a case report. Turk Kardiyol Dern Ars. 2013;41:161–5.
Lopes LM, Cha SC, Kajita LJ, Aiello VD, Jatene A, Zugaib M. Balloon dilatation of the aortic valve in the fetus. A case report. Fetal Diagn Ther. 1996;11:296–300.
Friedman KG, Sleeper LA, Freud LR, Marshall AC, Godfrey ME, Drogosz M, et al. Improved technical success, postnatal outcome and refined predictors of outcome for fetal aortic valvuloplasty. Ultrasound Obstet Gynecol. 2018;52:212–20.
Kohl T, Sharland G, Allan LD, Gembruch U, Chaoui R, Lopes LM, et al. World experience of percutaneous ultrasound-guide balloon valvuloplasty in human fetuses with severe aortic valve obstruction. Am J Cardiol. 2000;85:1230–3.
Simpson JM, Sharland GK. Natural history and outcome of aortic stenosis diagnosed prenatally. Heart. 1997;77:205e10.
Brackley KJ, Kilby MD, Wright JG, Brawn WJ, Sethia B, Stumper O, et al. Outcome after prenatal diagnosis of hypoplastic left-heart syndrome: a case series. Lancet. 2000;356:1143e7.
Dauterman K, Massie B, Gheorghiade M. Heart failure associated with preserved systolic function: a common and costly clinical entity. Am Heart J. 1998;135:5310–9.
Angeja BG, Grossman W. Evaluation and management of diastolic heart failure. Circulation. 2003;107:659–63.
McElhinney DB, Vogel M, Benson CB, Marshall AC, Wilkins-Haug LE, Silva V, et al. Assessment of left ventricular endocardial fibroelastosis in fetuses with aortic stenosis and evolving hypoplastic left heart syndrome. Am J Cardiol. 2010;106:1792–7.
Lofland GK, McCrindle BW, Williams WG, Blackstone EH, Tchervenkov CI, Sittiwangkul R, et al. Congenital heart surgeons society. Critical aortic stenosis in the neonate: a multi-institutional study of management, outcomes, and risk factors. J Thorac Cardiovasc Surg. 2001;121:10–27.
Mocellin R, Sauer U, Simon B, Comazzi M, Sebening F, Bühlmeyer K. Reduced left ventricular size and endocardial fibroelastosis as correlates of mortality in newborns and young infants with severe aortic valve stenosis. Pediatr Cardiol. 1983;4:265–72.
McElhinney DB, Marshall AC, Wilkins-Haug LE, Brown DW, Benson CB, Silva V, et al. Predictors of technical success and postnatal biventricular outcome after in utero aortic valvuloplasty for aortic stenosis with evolving hypoplastic left heart syndrome. Circulation. 2009;120:1482–90.
Freud LR, McElhinney DB, Marshall AC, Marx GR, Friedman KG, del Nido PJ, et al. Fetal aortic valvuloplasty for evolving hypoplastic left heart syndrome: postnatal outcomes of the first 100 patients. Circulation. 2014;130:638–45.
Moon-Grady AJ, Morris SA, Belfort M, Chmait R, Dangel J, Devlieger R, et al. International fetal cardiac intervention registry: a worldwide collaborative description and preliminary outcomes. J Am Coll Cardiol. 2015;66:388–99.
We thank Angela Morben, DVM, ELS, from Edanz Group (https://en-author-services.edanzgroup.com/), for editing a draft of this manuscript.
No funding was received for this study.
Ethics approval and consent to participate
Consent for publication
Parent for both cases had signed consent for publication.
All authors declare no conflict of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Atiyah, M., Kurdi, A., Al Tuwaijry, O. et al. Fetal aortic valvuloplasty: first report of two cases from Saudi Arabia. J Cardiothorac Surg 15, 150 (2020). https://doi.org/10.1186/s13019-020-01195-y
- Aortic valve stenosis
- Fetal aortic Valvuloplasty
- Fetal echocardiography